Method of removing antibody free light chains from blood
    3.
    发明授权
    Method of removing antibody free light chains from blood 有权
    从血液中清除抗体自由轻链的方法

    公开(公告)号:US07875183B2

    公开(公告)日:2011-01-25

    申请号:US11599849

    申请日:2006-11-15

    摘要: There is provided a method of reducing blood free light chain concentration in a subject, the method comprising the step of subjecting the subject's blood to haemodialysis, haemodiafiltration or haemofiltration. There is also provided the use of a dialysis membrane which is a membrane that allows passage of molecules having a molecular weight of up to 45 kDa in presence of whole blood, and has a molecular weight exclusion limit in water of about 200 kDa in the preparation of a haemodialysis unit for conducting haemodialysis, haemodiafiltration or haemofiltration on a subject to reduce blood free light chain concentration in the patient.

    摘要翻译: 本发明提供减少受试者血液中无血液轻链浓度的方法,该方法包括使受试者的血液进行血液透析,血液透析或血液透析的步骤。 还提供了透析膜的使用,该透析膜是允许在全血存在下具有高达45kDa分子量的分子通过的膜,并且在制剂中具有约200kDa水分子排阻极限 的血液透析单元,用于对受试者进行血液透析,血液透析过滤或血液过滤,以减少患者中的血液轻链浓度。

    Method of removing antibody free light chains from blood
    8.
    发明申请
    Method of removing antibody free light chains from blood 有权
    从血液中清除抗体自由轻链的方法

    公开(公告)号:US20070251882A1

    公开(公告)日:2007-11-01

    申请号:US11599849

    申请日:2006-11-15

    IPC分类号: B01D17/12 B01D15/08

    摘要: There is provided a method of reducing blood free light chain concentration in a subject, the method comprising the step of subjecting the subject's blood to haemodialysis, haemodiafiltration or haemofiltration. There is also provided the use of a dialysis membrane which is a membrane that allows passage of molecules having a molecular weight of up to 45 kDa in presence of whole blood, and has a molecular weight exclusion limit in water of about 200 kDa in the preparation of a haemodialysis unit for conducting haemodialysis, haemodiafiltration or haemofiltration on a subject to reduce blood free light chain concentration in the patient.

    摘要翻译: 本发明提供减少受试者血液中无血液轻链浓度的方法,该方法包括使受试者的血液进行血液透析,血液透析或血液透析的步骤。 还提供了透析膜的使用,该透析膜是允许在全血存在下具有高达45kDa分子量的分子通过的膜,并且在制剂中具有约200kDa水分子排阻极限 的血液透析单元,用于对受试者进行血液透析,血液透析过滤或血液过滤,以减少患者中的血液轻链浓度。

    Filter device having more than one filtration compartment
    10.
    发明授权
    Filter device having more than one filtration compartment 有权
    具有多于一个过滤隔室的过滤装置

    公开(公告)号:US07790029B2

    公开(公告)日:2010-09-07

    申请号:US10708774

    申请日:2004-03-24

    IPC分类号: B01D63/02 B01D63/04 B01D61/00

    摘要: A filter device having filter means, in particular hollow fiber membranes, arranged in more than one filtration compartment within a filter housing. The filter device thereby allows more than one filtration process to be carried out serially and/or simultaneously within a single housing. For example a dialysis type filtration process such as hemofiltration or hemodiafiltration or hemodialysis may be carried out at the same time as an ultrafiltration process or as another hemofiltration, hemodiafiltration or hemodialysis process. The device may have a split shell construction bonded or welded together along longitudinal seams. Internal separating walls within the housing are formed integrally with the shell portions of the housing to form adjacent filtration compartments when the housing portions are joined together.

    摘要翻译: 具有过滤器装置,特别是中空纤维膜的过滤装置,其布置在过滤器壳体内的多于一个过滤隔室中。 因此,过滤装置允许在单个壳体内串联和/或同时进行多于一个的过滤过程。 例如,透析型过滤方法如血液滤过或血液透析过滤或血液透析可以在超滤方法的同时进行,或作为另一种血液透析,血液透析过滤或血液透析过程进行。 该装置可以具有沿纵向接缝焊接或焊接在一起的分裂壳结构。 当壳体部分接合在一起时,壳体内部的分隔壁与壳体的壳体部分形成一体,以形成相邻的过滤隔室。